This article introduces Targeted Smooth Bayesian Causal Forests, or tsbcf, a semiparametric Bayesian approach for estimating heterogeneous treatment effects which vary smoothly over a single covariate in the observational data setting. The tsbcf method induces smoothness in estimated treamtent effects over the target covariate by parameterizing each tree's terminal nodes with smooth functions. The model allows for separate regularization of treatement effects versus prognostic effect of control covariates; this approach informatively shrinks towards homogeneity while avoiding biased treatment effect estimates. We provide smoothing parameters for prognostic and treatment effects which can be chosen to reflect prior knowledge or tuned in a data-dependent way.
Introduction
Home use of mifepristone and misoprostol to induce abortion in the first nine weeks of gestation is safe and preferable to women over use in the clinic setting (Gold and Chong, 2015; Ngo et al., 2011) . However, in England and Wales, the law does not permit use of abortion medications outside of registered medical facilities (Abortion Act, 1967 (c.87 ).
The current recommended regimen for medical abortion up to 63 days of gestation in Britain is 200 mg oral mifepristone followed by 800 micrograms vaginal misoprostol 24-48 hours later (of Obstetricians and Gynaecologists, 2011) . This ''inverval" protocol requires a minimum of two clinic visits, which imposes financial and logistical burdens on women's access to medical abortion. Prior research shows that simultaneous dosing of mifepristone and misoprostol is on average 97% as effective as interval administration and is strongly preferred by women (Lohr et al., 2018) . British Pregnancy Advisory Services, a non-profit abortion provider with 60 clinics in England and Wales, introduced the option of in-clinic simultaneous dosing in 2015. In the absence of legal home use, simultaneous dosing reduces barriers to access.
Patients choose which regimen they prefer, and practitioners must provide guidance which balances relative effectiveness of the two regimens versus accessibility. A key clinical question is whether the relative effectiveness for simultaneous versus interval administration varies at later gestational ages, for specific subgroups of women, or a combination. Previous work uses logistic regression with propensity score quintiles to adjust for self-selection to treatment protocol, and considers gestation discretized by weeks seven and earlier, week eight, and week nine (Lohr et al., 2018) . While this analysis did not find signifant decreases in relative effectiveness as gestation advanced, it did not allow for smooth change in effectiveness over gestation, nor does it allow for nuanced subgroup analysis and careful regularization of heterogeneous treatment effects.
Let function f (t, x, z) represent the probability of successfully early medical abortion occuring at gestational age t (in half-weeks), for a patient with maternal covariates x, who selected regimen z. Let z = 1 be the ''treatment", or simultaneous, and z = 0 be the ''control", or interval, regimens. We write this function as the sum of prognostic effect and treatment effect, f (t, x, z) = µ(t, x) + τ (t, x)z. The first goal of this paper is to formulate a model which provides better estimates of τ (t, x), when τ (t, x) evolves smoothly over t but not necessarily x, where the model is carefully regularized to provide unbiased causal estimates for observational data.
The second goal is to apply this model to the early medical abortion data to provide clinicians with accurate, smooth estimates of relative effectiveness over gestation for individual patients and clinically relevant subgroups. This work fills an important gap in ability to assess the relative effectiveness of early medical abortion regimens over time.
Current literature does not provide a way to characterize this function which allows for smooth evolution of the treatment effect as gestation progresses. In addition, while clinicians expect that relative effectiveness should evolve smoothly over gestation, there is not strong prior knowledge regarding potential heterogeneity in treatment groups and how that heterogeneity may change over gestation. We apply our model to data from the British Pregnancy Advisory Service to estimate τ (t, x), providing clinicians with smooth estimates of relative effectiveness over gestation for both individuals, as well as conditional average relative effectiveness estimates for subgroups of patients.
To estimate heterogeneous treamtent effects which evolve smoothly over a target covariate (gestation), we propose a new ensemble-of-trees model called Targeted Smooth Bayesian Causal Forests. Our approach is based on the very successful Bayesian Additive Regression Trees (BART) model, introduced by Chipman et al. (2010) . Our approach is based on the very successful Bayesian Additive Regression Trees (BART) model, introduced by Chipman et al. (2010) . The BART model is a Bayesian tree ensemble model for regression, which predicts scalar response y as the sum of binary regression trees over covariates x. Trees are regularized by a prior to be ''weak learners", i.e. to be shallow with relatively few splits, to avoid overfitting. Our model leverages two BART extensions: the BART with Targeted Smoothing (tsBART) framework of Starling et al. (2019) and the carefully regularized Bayesian Causal Forests (bcf) model of Hahn et al. (2017) . BART with Targeted Smoothing adapts the BART framework to induce smoothness over a single target covariate, and has been shown to outperform regular BART in when the underlying regression function is in fact smooth over this covariate. Bayesian Causal Forests adapts the BART framework to predict heterogeneous treatment effects, and regularizes the prior to avoid biased treatment effect estimation. Motivated by modeling relative effectiveness of early medical abortion regiments over gestation, our tsbcf model builds on the BART framework, extending both aforementioned models in order to model smooth heterogeneous treatment effects for observational data.
In Section 2 we provide an overview of the early medical abortion regimens and the dataset. Section 3 details the tsbcf model and reviews relevant work. Section 4 presents results of a simulation study showing the advantages of tsbcf for several clinically relevant treatment effect scenarios. Section 5 presents results of the early medical abortion analysis using the tsbcf method. Section 6 contains discussion. Section 7 provides supplemental materials; the R package tsbcf implements our method. The Appendix provides additional detail on fitting the tsbcf model.
Early Medical Abortion Regimens

Background.
Mifepristone and misoprostol are used together to induce medical abortion through the ninth week of gestation. The recommended regimen for early medical abortion in Britain is 200 mg oral mifepristone, followed by 800 micrograms vaginal misorprostol 24-48 hours later (of Obstetricians and Gynaecologists, 2011) . This ''inverval" protocol requires a minimum of two clinic visits, which imposes financial and logistical burdens on women's access to medical abortion. British Pregnancy Advisory Services, a non-profit abortion provider with 60 clinics in England and Wales, introduced the option of in-clinic simultaneous dosing in 2015; in this regimen, mifepristone and misoprostol are administered in a single clinic visit. Simultaneous dosing of mifepristone and misoprostol has been shown to be 97% as effective on average as interval administration, and is strongly preferable; 85% of the women observed chose simultaneous over interval (Lohr et al., 2018) . Simultaneous dosing eliminates the need for a second clinic visit, reducing barriers to access.
Patients select which protocol to undertake, and depend on clinicians' guidance as to the relative effectiveness of each choice. Knowledge of whether there is any change in relative effectiveness as gestation progresses, and whether there are subgroups of patients who should be counseled differently, allows clinicians to provide more accurate and personalized information to their patients. Uncertainty quantification is also a key component of providing patients with comprehensive guidance.
Previous research (Lohr et al., 2018) investigates whether relative effectiveness decreases at later gestational ages, and does not find evidence of a significant drop in effectiveness for simultaneous versus interval dosing as gestational age increases. This work uses a logistic regression model with gestational age groups and propensity score quintiles as covariates; gestational age is discretized into 49 days or less, 50-56 days, and 57-63 days. A limitation of this model is the discretization of gestation, as the model does not provide a smooth estimate of the impact of gestational age progress on relative effectiveness. A second limitation is that while inclusion of propensity score estimates may help adjust for biased treatment effect estimates due to self-assignment, the model lacks regularization to reduce bias in the presence of potential targeted selection (Hahn et al., 2018) . This model does not allow for exploration of subgroups or nuanced estimation of individual treatment effects over gestation. Our model improves on this previous approach with careful regularization, uncertainty quantification, smoothness over gestational age, and estimates of both subgroup and individual-level relative effectiveness estimates.
Data description.
We use observational data from early medical abortions provided at British Pregnancy Advisory Service clinics from May 1, 2015 to April 30, 2016. Data was collected from British Pregnancy Advisory Service's electronic booking and invoicing system, which contains records of services provided to clients, including selected demographic and clinical characteristics. These data are initially entered by telephone operators at British Pregnancy Advisory Service's telephone contact center; details are then validated by clinicians at both in-person consultations and at treatment appointments. Complications and adverse outcomes are identified during post-treatment follow-up visits, or British Pregnancy Advisory Services is notified by other providers or by women themselves.
When possible, hospital discharge summaries or documents from general practitioners are obtained to confirm outcomes. Staff cross-check the booking and invoicing system for any appointments with British Pregnancy Advisory Services after the date of treatment, and hand-check medical records if a continuing pregnancy or incomplete abortion was recorded in the complications database. This study was approved and exempted from full human subjects review by British Pregnancy Advisory Services and The University of Texas at Austin since all data were pre-existing and were provided in a fully de-identified format.
The dataset consists of 28,895 independent patient records. The sample consists of women with pregnancies of between 4.5 weeks (32 days) 9 weeks (63 days) gestation or less as determined by abdominal or vaginal ulstrasonography, who wanted a medical abortion, and who had no contraindications. Early medical abortion is available through 9 weeks of gestation. While 4 weeks is typically the earliest a patient is aware of the pregnancy, only 12 women obtained early meidcal abortions below 4.5 weeks; our analytic sample begins at 4.5 weeks. Women were offered the choice between 200 mg oral mifepristone followed by 800 micrograms vaginal misoprostol within 15 minutes (simultaneous administration), or 24-72 hours later. Women chose their preferred regimen after being informed of expected differences in side effects and outcomes. Our analytic sample consists of women who chose simultaneous dosing or a 24-48 hour interval between medications.
The binary response is a successful early medical abortion outcome, defined as complete expulsion of uterine contents after early medical abortion, without surgical intervention and without continuing pregnancy, as defined by the Medical Abortion Reporting of Efficacy Guidelines Creinin and Chen (2016) . Women could choose to return two weeks post-treatment for a vaginal ultrasound, or could use a low-sensitivity urine pregnancy test (detection limit 1,000 international units human chorionic gonadotrophin) and symptom checklist to self-report the outcome of the abortion (Cameron et al., 2015) . Women could schedule a clinic visit at any time to address concerns or symptoms of a possible complication, including continuing pregnancy. Women diagnosed at a follow-up visit with a retained nonviable sac or embryo were offered the choice of another 800 micrograms vaginal mifepristone or surgical evacuation, and women diagnosed with continued pregnancy were offered surgical evacuation; all of these are considered unsuccessful procedures.
Targeted Smooth Bayesian Causal Forests
Targeted Smooth Bayesian Causal Forests (tsbcf) offers a promising technique for estimating relative effectiveness of simultaneous versus interval administration of mifepristone and misoprostol. Suppose that x i represents available covariates for patient i: maternal age (years), Body Mass Index (kg/m 2 ), maternal ethnicity (Asian, Black, Other, Not Reported, white), and the numbers of previous abortions, births, Cesarean sections, and miscarriages. Let t i represent the gestational age at which early medical abortion occurred, in discrete half-week milestones ranging from 4.5 (32 days) to 9 (63 days).
We begin by briefly reviewing the original BART framework on which our method is based (Chipman et al., 2010) . We then review BART with Targeted Smoothing (Starling et al., 2019) and Bayesian Causal Forests (Hahn et al., 2017) , the two BART extensions we leverage in development of our model. We then introduce our Targeted Smooth Bayesian Causal Forests method, discuss model assumptions and modeling a binary response, followed by a re-view of relevant literature.
The BART model.
We The partition and leaves define a piecewise constant function,
Each of the L regression trees are additively combined into a single estimate f (x) = n l=1 g l (x). The BART prior constrains the g l functions to favor small trees and leaf parameters that are close to zero; in this way, trees are ''weak" learners, regularizing BART to avoid overfitting. Each tree independently follows the prior described in Chipman et al. (2010) , where probability that a node splits at depth h is given by η (1 + h) −β where η ∈ (0, 1) and β ∈ [0, inf). The leaf parameters are given independent priors m lb ∼ N (0, σ 2 m ) Chipman et al. (2010) suggest letting η = 0.95 and β = 2 to put low probability on deep trees with many splits. They also suggest using σ 0 to calibrate the possible range of estimated f (x) values, as the induced marginal prior of f (x) is centered at zero with approximately 95% of the prior mass ±2σ 0 . Model fitting is accomplished using an MCMC Bayesian Backfitting algorithm; we refer readers to the original paper for full details.
BART has been successful in a variety of contexts including prediction and classification (Chipman et al., 2010; Murray, 2017; Linero and Yang, 2017; Linero, 2018; Hernández et al., 2018) , survival analysis (Sparapani et al., 2016; Starling et al., 2019) , and causal inference (Hill, 2011; Hahn et al., 2017; Logan et al., 2017; Sivaganesan et al., 2017 ).
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BART with Targeted Smoothing
The BART model is known for excellent predictive performance but lacks smoothness. Observations consist of (y i , t i , x i ) where x i is the vector of unsmoothed covariates and t i is the value of the target covariate. Then the model is formulated as
The BART with Targeted Smoothing model is fit using intuitive extensions to the Bayesian Backfitting detailed in Chipman et al. (2010) , and requires an additional parameter specification: κ, a smoothness parameter, regulates the lengthscale of the Gaussian Process prior. Starling et al. (2019) provide an intuitive default and tuning suggestions for this parameter, while other parameter settings mirror the original BART method.
Bayesian Causal Forests
Bayesian Causal Forests (bcf) extends the BART framework to estimate heterogeneous treatment effects for observational data (Hahn et al., 2017) . The bcf model specifies that the prognostic BART fit includes propensity score estimates as a covariate to improve treatment effect estimation in the presence of confounding. Improvement is particularly pronounced when confounding is due to targeted selection, in which individuals select the treatment protocol based on predictions of the potential outcomes (Hahn et al., 2018) .
Observations consist of (y i , z i , x i ), where y i indicates response, z i binary treatment, and
x i is the vector of covariates. Letπ(x i ) be estimates of the propensity score
The bcf model is formulated as
where µ and τ are the prognostic and treatment BART fits. The goal is estimating conditional average treatment effects (CATE) -the amount by which response y i differs in the cases where z i = 1 versus z i = 0, notated using the counterfactual outcomes framework of Imbens and Rubin (2015) where y i (0) and y i (1) denote potential outcomes under control versus treatment. In this framework, observations correspond to realized trea-
. Then the causal estimand is expressed as
The bcf model has desirable qualities for modeling relative effectiveness of early medical abortion protocols. We could include gestational age in the covariate vector x. However, bcf lacks any mechnanism to induce smoothness over gestational age, consistent with clinical intuition.
Targeted Smooth Bayesian Causal Forests
Let y denote a scalar response, and z a binary treatment indicator. Let x denote a plength vector of observed control variables, and t a scalar target variable over which we wish to induce smoothness. Consider an observed sample of independent observations
n}. We introduce Targeted Smooth Bayesian Causal Forests
(tsbcf), a method which leverages the frameworks of tsBART and bcf to model heterogeneous treatment effects which vary smoothly over t while providing appropriate regularization to avoid biased treatment effect estimates.
We restrict to the mean-zero additive error setting
and the treatment effect of letting z i = 1 versus
We then model the response surface E(
which allows for direct specification of a prior over the treatment effects. We also include the estimated propensity score in the estimation of the prognostic effect. We use variants of the tsBART prior to model µ and τ .
To model µ, we use the default tsBART prior with 200 trees, depth penalty β = 2, splitting probability η = 0.95, and smoothing parameter κ µ = 1, with a half-Cauchy prior on the scale of leaf parameters (Gelman, 2006; Starling et al., 2019) . For modeling τ , we prefer the tsBART prior to have stronger regularization to reflect our belief that treatment effect heterogeneity is generally simple over covariates and time. We let κ τ = 1 to reflect heterogeneity over t. We use 50 trees and set β = 3 and splitting probability η = 0.25 to shrink towards homogeneity in x. We replace the half-Cauchy prior with a half-Normal prior on the scale of the leaves, with median set to the marginal standard deviation of y.
We assign σ 2 an inverse chi-squared prior, σ 2 ∼ νλ/χ 
Assumptions
Throughout the paper, we make the stable unit treatment value (SUTVA) assumption, which excludes interference between units and multiple versions of treatment (Imbens and Rubin, 2015) . We also assume that strong ignorability holds, which stipulates that there is no unmeasured confounding so that
and there is sufficient overlap to estimate treatment effects everywhere in covariate space such that
for all i ∈ 1, . . . , n observations.
Modeling a Binary Response
In the original BART paper, Chipman et al. (2010) provide a probit version of the BART model for binary outcomes Y ∈ {0, 1}.
where Φ is the standard normal CDF and G(x) is the standard BART model. Inference is accomplished via data augmentation using the method of Albert and Chib (1993) . The tsBART method may be similarly augmented.
The tsbcf model can be extended in the same way for the binary early medical abortion outcomes. Let c i be the observed binary response for i ∈ {1, . . . , n}, with target covariate t i , treatment indicator z i , and vector of covariates x i . Let y i be the Gaussian latent variable, then similar to the original BART model, we write our model as follows. Let
, where
Counterfactual probabilities of success are
so for observation i, causal estimands are expressed on the probability scale as Absolute Risk Reduction:
Relative Risk:
Number Needed to Treat:
We include propensity score estimates and covariate vector x i in estimation of prognostic effects. We refer readers to Rosenbaum and Rubin (1983) ; Hahn et al. (2017) for a detailed discussion of reasons for including both; briefly, inclusion of propensity score is an effective dimension-reduction technique which yields a prior that flexibly adapts to complex patterns of confounding, and control covariates (instead of only propensity score) are necessary for identifying heterogeneous treatment effects, particularly when we do not believe that the response depends on covariates x strictly through the propensity score.
Connection with existing work.
Our paper builds on several other extensions to the Bayesian tree-modeling framework.
We leverage two papers in particular in formulating the tsbcf model. The first is Hahn et al. (2017) , who propose the Bayesian Causal Forest (bcf) model. Their model estimates heterogeneous treatment effects from observational data using the BART framework, with separately regularized BART priors for prognostic and treatment effects. This approach allows for separate regularization of the treatment effect, allowing for shrinking towards homogeneity. Their method is particularly careful in handling two closely related phenomenon: targeted selection and regularization induced confounding.
Targeted selection occurs when selection into treatment is based in part on expected outcomes under control, µ(t, x), where the probability of treatment is generally increasing or decreasing as some function of this estimate. (This implies some functional relationship between propensity scores π and expected outcomes under treatment µ.) This seems a likely scenario in the early medical abortion case, where clinicians may be likely to caution patients they percieve as high-risk more strongly about potential decrease in effectiveness of the simultaneous regimen. Additionally, for accessibility reasons, clinicians may provide more conservative advice to patients at more advanced gestational ages.
Estimation of treatment effects is complex because the minimal set of control variables is generally never known, and there are often many candidate control variables.
Regularization therefore plays a key role in accurate treatment effect estimation, but in settings with confounding and modest treatment effects, biased treatment effects can occur if regularization is not performed carefully. Hahn et al. (2018) 
Simulations
We compare tsbcf to several existing models in a benchmarking study designed to simulate five clinically plausible treatment effect scenarios. We generate prognostic effects, treatment effects, and random noise for each scenario, and assess how well each model recovers the treatment effects. We compare the following models.
• bcf: The Bayesian Causal Forest model described in Hahn et al. (2017) . We expect this model to perform well but lack smoothness ( Figure 7 ).
• hillbart: Ordinary BART used to model the response surface in the causal inference setting (Hill, 2011) .
• lm: A linear model of the form Y = Xβ+ZXα where design matrices X include the target covariate, all other covariates, and two-and three-way interactions between all predictors, including the target covariate.
• psbart: Ordinary BART with estimated propensity scores included as a covariate (Rosenbaum and Rubin, 1983 ).
• splines: A linear model with cubic B-splines with 7 degrees of freedom modeling the target covariate, and two-and three-way interactions among all predictors, including the target covariate splines.
• tsbcf default: The tsbcf method, with smoothing parameters κ µ = 1 and κ τ = 1.
• tsbcf wiggly: The tsbcf method, with smoothing parameters κ µ = 1 and κ τ = 3.
Simulated data is generated as follows. For independent observations i ∈ {1, . . . . , n}, draw a vector of covariates
∼ N (0, 1) and draw target covariate
based a binomial draw with propensity score
where ρ ∈ [0, 1] controls the amount of targeted selection; ρ controls the degree to which the propensity score is based on a somewhat accurate prediction of the potential outcome, since
is found in the prognostic effect (Equation 20), while x 4i and x 5i are not used in prognostic or treatment effect generation. We generate estimates for the propensity scoresπ i using the dbarts R package (Chipman et al., 2010) ; any accurate prediction is viable, as in Hahn et al. (2017) .
We then generate observations as
where µ is the prognostic function and τ is the treatment effect function. The prognostic function is the same for all five scenarios:
We vary τ (t i , x i ) by scenario, reflecting different treatment effects as follows.
• Scenario A represents a treatment effect that varies smoothly over the target covariate t, with homogeneity in x.
τ (t i , x i ) = 2.5 + 0.75t i − 0.05 sin(2πt i )
• Scenario B represents heterogeneous treatment effects that vary smoothly over t with modest differences in subgroups.
• Scenario C represents heterogeneous treatment effects, similar to Scenario B except that the effects of t and x are inseparable.
• Scenario D gives heterogeneous treatment effects with small effects in general, except for a small subgroup with a pronounced effect.
• Scenario E is a constant treatment effect, requiring shrinking to homogeneity in both x and t.
τ (t i , x 3i ) = 3
Let σ 2 = 1 for all scenarios. This setting scales treatment effects to be relatively modest compared to prognostic effects (roughly a third of the magnitude), and scales random noise appropriately to the size of the treatment effects. : RMSE for recovering the conditional average treatment effects (CATE) for subgroups in each scenario across the target covariate. RMSE is averaged over 100 replicates of the simulation, each consisting of generating a dataset and fitting the models. The rows give results for two sample sizes. We compare several models; tsbcf default and tsbcf wiggly are tsbcf with default (κ µ = 1, κ τ = 1) and less smooth (κ µ = 1, κ τ = 3) settings. Both tsbcf models perform comparably to the bcf model while inducing the desired smoothness. Results confirm that we have achived the goal to induce smoothness while not compromising accurate heterogeneous treatment effect estimation. The linear and spline model estimates are biased due to generation of the simulation with some confounding, to mimic realistic observational data scenarios; regular BART methods are less robust to this confounding, while bcf and tsbcf are designed to be robust due to separate regularization of the treatment tree fit.
vals than other methods, and bcf has slightly inflated variance due to lack of smoothness over the target covariate. Panel C gives interval length versus RMSE, and tsbcf has both shortest interval length and lowest RMSE, for both smoothness settings. Together, these panels demonstrate that in scenarios where the underlying treatment effect is smooth over the target covariate, tsbcf recovers the heterogeneous treatment effects while maintaining coverage and yielding reasonable measures of uncertainty. Coverage versus RMSE, where the lower-right frontier gives the optimal frontier of low RMSE combined with good coverage. All methods maintain approximately nominal (95%) coverage while the tsbcf methods have lower RMSE. The ''default" tsbcf outperforms the ''wiggly", as the true treatment effects are very smooth over the target covariate; however, the ''wiggly" version is still outperforming other methods. (B) Coverage versus interval length. Both tsbcf settings have slightly narrower intervals than other methods, and bcf has slightly inflated variance due to lack of inducing smoothness over the target covariate. (C) Interval length versus RMSE, and tsbcf has both shortest interval length and lowest RMSE for both smoothness settings. Together, these demonstrate that in scenarios where the underlying treatment effect is smooth over the target covariate, tsbcf recovers the heterogeneous treatment effects while maintaining coverage and yielding reasonable measures of uncertainty.
Results for Early Medical Abortion Modeling
We now focus on our scientific problem, estimating relative effectiveness of simultaneous versus interval administration of mifepristone and misoprostol in early medical abortion. We apply tsbcf to the British Pregnancy Advisory Services data described in Section 2. We model the probability of successful early medical abortion across gestational age, τ (t, x), using the probit extension of the tsbcf (Section 3.6). Our target covariate for smoothing is gestational age in half-weeks, t i ∈ {4.5, 5, 5.5, . . . , 9}, where 4.5 indicates 32-34 days gestation, 5 weeks indicates 35-38 days, 5.5 indicates 39-41 days, and so on. Let c i be a binary indicator for successful early medical abortion, and z i be a binary indicator for simultaneous (z i = 1) versus interval (z i = 0) regimen. Let x i be the vector of patient characteristics, including age in years, body mass index (kg/m 2 ), maternal ethnicity, and numbers of previous abortions, births, Cesarean sections, and miscarriages.
Our goal is to provide clinicians with a smooth estimate of relative effectiveness of simultaneous versus interval protocols across gestational age, to provide accurate advice to women selecting a protocol. We are interested in knowing average relative effectiveness across gestation, as well as whether there are subgroups of patients where relative effectiveness over gestation differs. Relative effectiveness is calculated as the ratio between the two counterfactual treatment effect estimates on the probability scale. Let y i be the pro- i for each patient at each gestational age; we can then average across patients at each gestational age to obtain each MCMC draw of the ∆ and RR for a given gestation, or average across subgroups of patients to obtain MCMC draws of the ∆ and RR for that subgroup at a given gestation.
We summarize results by calculation posterior mean and 95% credible intervals at each gestational age. For MCMC draws b ∈ {1, . . . , B}, RR
i is the b th MCMC draw for relative risk for individual i who is observed at gestational age t i . Then we obtain posterior draws of estimated relative effectiveness at some gestational age t aŝ We fit the tsbcf model to the early medical abortion data and calculate posterior mean relative effectiveness at each half-week of gestation. Mean posterior relative effectiveness of 0.95 at some gestational age t is clinically interpreted as the simultaneous protocol being 95% as effective as the interval protocol on average at gestational age t. (Table 1) .
Number needed to treat (NNT) gives the number of women who would need to be treated under the simultaneous protocol instead of interval before one additional failed procedure is observed than would occur under interval administration. Figure 5 , panel B
gives the posterior mean NNT and 95% credible interval. While there is a slight decrease in relative effectiveness as gestation advances, the average relative effectiveness remains high over the course of gestation. We also note the large interval including zero at 4.5 weeks; the posterior relative risk is close to 1 here, with credible interval bounds falling on each side of one, indicating that simultaneous and interval protocols are nearly equally effective this early in gestation.
After averaging over the cohort, we aim to identify subgroups of women with heterogeneity in relative effectiveness. We take a ''fit-the-fit" approach to subgroup analysis (Hahn et al., 2017) where we use individual relative effectiveness estimates are used as We note the relatively small sample size at 9 weeks, resulting in a slight kick-up that we do not believe is clinically relevant, as well as inflated uncertainty (Table 1) . (B) Posterior mean number needed to treat (NNT), giving the average number of patients needed to receive treatment under the simultaneous regimen before one additional early medical abortion failure is observed compared to failures under the interval regimen. While there is a slight decrease in relative effectiveness as gestation advances, the average relative effectiveness remains high over the course of gestation.
the response. Individual posterior mean relative effectiveness estimate are calculated aŝ
To assess subgroup heterogeneity, we focus on women where gestational age is in the 7-9 week range; this is the clinically interesting area of the posterior mean relative effectiveness curve in Figure 5 . The individual relative effectiveness estimates,RR i , for women where t i ∈ 7, . . . , 9 are used as inputs to a CART model Chipman et al. (1998) , with x i as covariates. Figure 6 gives the tree fit from the CART model. Each tree node in the figure contains the posterior mean relative effectiveness and the percent of observations for that node.
In parenthesis below each terminal node is the NNT corresponding to the relative effec- Figure 6 : Tree from the ''fit-the-fit" CART model to investigate subgroups, where response is individual relative effectiveness estimate, and covariates are patient characteristics. Each node contains the posterior mean relative effectiveness and the percent of observations contained in that split or terminal node. In parenthesis below each terminal node is the NNT corresponding to that node's relative effectiveness. Age is first split, and so the most important subgroup; patients 29 and older see somewhat decreased relative effectiveness compared to their younger counterparts. Within the older and younger groups of patients, number of previous births also decreases relative effectiveness, though slightly less so in the younger group of patients.
The CART fit gives point estimates of mean posterior relative effectiveness for each node. We query the posterior draws for subgroups at each level of the CART tree. Less overlap in the posterior densities indicates meaningful splits. Concentration of the posterior densities indicates more precisely isolated subgroups as a result of the tree split, and more dispersion indicates greater heterogeneity within a tree split subgroup. To summarize, age split at 29 is an important subgroup, with somewhat decreased relative effectiveness in the older cohort. Within the younger and older cohorts, presence of previous births had a slight negative impact on relative effectiveness, which was more pronounced in patients 29 and older, less in patients 22-28, and not present in patients under 22.
In order to get a better understand the difference in relative effectiveness between subgroups in terms of patient impact, Figure 8 gives a histogram of differences in subgroup average NNT for women age 29 or older with ethnicity white, Other, or Not Reported, and two or more previous births versus women under 22 (Leaf 6). These subgroups correspond to comparing Leaf 1 and Leaf 6 of the CART tree ( Figure 6 ). The histogram plots PPosteriors for all three leaves on the left side of the tree. Women in Leaf 1 appear to have somewhat lower relative effectiveness than women in Leaves 2 and 3. In summary, age is the most important covariate defining subgroups, with a split at age 29. Within each age group, previous births decrease relative effectiveness slightly.
the distribution of subgroup average NNT difference for each MCMC draw. Differences generally range from 20 to 60 patients, with no mass at zero, indicating that the difference in these subgroups translates to real differences in number of women at later gestational ages (7-9 weeks) who would need to receive the simultaneous protocol instead of interval before seeing one additional failed procedure. Histogram of MCMC draws of differences in subgroup average NNT for women age 29 or older, with ethnicity white, Other, or Not Reported, and two or more previous births versus women under 22. These subgroups correspond to comparing Leaf 1 and Leaf 6 of the CART tree ( Figure 6 ). Differences generally range from 20 to 60 patients, with no mass at zero, indicating that the difference in these subgroups translates to real differences in number of women who would need to receive the simultaneous regimen instead of interval before seeing an additional failed procedure. sis focused on averaging over the cohort or subgroups; these scatterplots show the full range of individual posterior relative effectiveness, as well as trends in age and previous birth consistent with Figures 6 and 7. The impact of age on relative effectiveness is stronger than that of previous births, however, increase in each covariate decreases relative effectiveness. Table 2 The impact of age on relative effectiveness is stronger than that of previous births, however, increase in each covariate decreases relative effectiveness. There are only a handful of patients whose estimates for relative effectiveness are below 0.90. Table 2 provides detail on cohort characteristics by posterior relative effectiveness, for women with estimates below 0.90, from 0.90-0.95, and above 0.95.
Gestational age is on the x-axis, with lines for age groups and previous number of births.
Panel A shows partial dependence of relative effectiveness on age over gestation, grouped by the CART tree splits on age (Figure 7 ). Panel B shows partial dependence of relative effectiveness on number of previous births. Plots support previous subgroup analysis findings.
The early medical abortion analysis uses our suggested default parameter settings for smoothness parameters (κ µ = 1 and κ τ = 1). We discuss parameter tuning in Section 3;
here, we perform a sensitivity analysis for robustness of our analysis to smoothness parameter choice. We let κ µ =1 and fit the tsbcf model to the early medical abortion dataset three times, with κ τ ∈ 1 3
, 1, 3 . These choices represent a three-times changes in magnitude in each direction, corresponding to varying the length-scale of the treatment trees'
covariance from one to three to nine. eter. While there are small differences in the overall estimated relative effectiveness, we do not see clinically meaningful variation from varying the smoothness, indicating that our analysis is robust to smoothing parameter choice. We also note small differences in the 9-week range of gestation, lending support to our intuition that the small increase at 9 weeks is due to small sample size.
Finally, in addition to helping clinicians provide better advice to each patient, clinics must plan appropriately for potential adjustments in staffing and resource needs when providing the simultaneous regimen as an option. To this end, we look at the treatment effect on the treated -for patients who selected the simultaneous regimen and experienced a failure, we plot the distribution of differences in the observed number of failures under simultaneous compared to the expected failures had those patients selected inter- Figure 11 : Posterior mean relative effectiveness for three settings of the tsbcf model's smoothness parameter for the treatment tree fit. The early medical abortion analysis was performed using the recommended default smoothness parameter settings (1 for both tree fits). The solid line matches Figure 1 , giving posterior relative effectiveness over gestational agewith shaded 95% posterior credible interval. We fit the same model twice more, setting the treatment tree fit's smoothness parameter κ τ to 1/3 (''smoother") and 3 (''wigglier"), reflecting shift in magnitude of three times in each direction. We do not see clinically meaningful differences in the three posterior mean estimates across gestation, indicating robustness to choice of smoothness parameter.
val over MCMC draws. We report this on the order of expected additional surgeries per thousand patients, giving clinics a sense of the volume of likely additional procedures.
We find that a clinic can expect approximately 40-60 additional surgeries per thousand patients ( Figure 12 ).
Discussion
Our Targeted Other hyperparameters are set efficiently using data-driven approaches as recommended in Hahn et al. (2017) and Chipman et al. (2010) . Additionally, like the previously mentioned BART-based methods, tsbcf handles is invariant to transformation of predictors, categorical predictors seamlessly, and mitigates the curse of dimensionality via regularization.
The analysis of relative effectiveness of the simultaneous medical abortion protocol versus interval protocol represents a substantial advancement on previous work (Lohr et al., 2018) , in robust handling of potential confounding, smoothness over gestational age, and assessing subgroups of patients with modest amounts of heterogeneity at later gestational ages. We validate the results of Lohr et al. (2018) weeks' gestation to a degree which should not make clinicians uncomfortable recommending the simultaneous regimen given its lower barriers to access. Our subgroup identification expands on previous findings; while the simultaneous regimen remains generally very effective, clinicians may wish to use our findings to inform advice to patients age 29 and greater who seek early medical abortion later in gestation (7-9 weeks), particularly those with two or more previous births.
One limitation of our work is the limited set of available covariates. It is plausible that unobserved confounders exist, and our method regularizes to guard against this bias;
however, more demographic information about patients may inform subgroup analy- Here we provide details on the model parameterization and prior for tsbcf. The model is comprised of the sum of two tsBART fits, each with its own prior specification. The model can be written in full as
where the prognostic tsBART fit is parameterized as in Starling et al. (2019) .
We calibrate the induced half-Cauchy prior's median s µ by setting it equal to the twice the marginal standard deviation of y. The variance of the squared exponential GP kernel is set to 1/200, and smoothness parameter κ µ = 1 governs the length-scale (Starling et al., 2019) . The prior on trees T µj is as in Chipman et al. (2010) , with depth penalty β = 2 and split probability α = 0.95. For the treatment effect fit, we parameterize to ensure the treatment effect is invariant to transformation, such that
This parameterization induces the prior b 1 − b 0 ∼ N (s b , 1) and we set s b to the marginal median of y. The prior on trees T τ j uses depth penalty β = 3 and split probability α = 0.25. The variance of the squared exponential GP kernel is set to 1/50, and smoothness parameter κ τ = 1 governs the length-scale. The prior for σ 2 follows Chipman et al.'s recommendation for a rough over-estimation ofσ. We choose ν = 3 and q = 0.90, and estimateσ by regressing y onto x (including the target variable as a covariate), then choose λ s.t. the qth quantile of the prior is located at σ, i.e. P (σ ≤σ) = q.
A2. Bayesian Backfitting Algorithm
We leverage the Bayesian backfitting MCMC algorithms of tsBART and bcf to design a Bayesian backfitting algorithm for tsbcf. We refer interested readers to Chipman et al. (2010) for a full discussion of the original Bayesian backfitting, and Starling et al. (2019) and Hahn et al. (2017) for tsBART and bcf algorithms respectively. Briefly, Bayesian backfitting involves an MCMC algorithm where each tree, and its parameters are sampled one at a time given the partial residuals from the other m − 1 trees. One iteration of the sampler consists of looping through the trees, sampling each tree T j via a Metropolis step, and then sampling its associated leaf parameters M j , conditional on σ 2 and the remaining trees and leaf parameters. After a pass through all trees, σ 2 is updated in a Gibbs step.
Updating trees and leaves
In general, to sample {T j , M j } conditioned on the other trees and leaf parameters T (j) , M (j) , define the partial residual as
Using r j as the working response vector, at step s of the MCMC one samples T (s) j by proposing one of four local changes to T (s−1) j , marginalizing analytically over M j . The local change is selected randomly from the following candidates:
• grow randomly selects a terminal node and splits it into two child nodes
• prune randomly selects an internal node with two children and no grandchildren, and prunes the children, making the selected node a leaf
• change randomly selects an internal node and draws a new splitting rule
• swap randomly selects a parent-child pair of internal nodes and swaps their decision rules
The change and swap moves are computationally expensive; in practice, BART is often implemented with only prune and grow proposals (Pratola et al., 2014) . Once the move in tree space is either accepted or rejected, M j is sampled from its Gaussian full conditional, given T j and σ 2 .
Distributional relationships
Our algorithm for fitting tsbcf retains the form of the method used in bcf, extended to the multivariate setting as in tsBART. The following distributional relationships are useful for deriving the full conditional distributions used in the backfitting updates.
• For µ(t i , x i ,π) the "data" is • For b 1 the "data" is
for only the z i = 1 observations.
• For b 0 , same as b 1 , using only the z i = 0 observations. Note that we use y i generally here; for updating tree and leaf parameters {T µj , M µj } and {T τ j , M τ j } respectively, we are using the partial residuals with all other trees and leaf parameters held constant as described above. For updating the prognostic fit µ(t i , x i ,π) r ij = y i − 200 k=1,k =j g (x k ; T µk , M µk ) and similarly, for updating the treatment fit τ (t i , x i ,π), the ''data" consist of the partial residuals r ij = y i − 50 k=1,k =j g (x k ; T τ k , M τ k )
Full conditionals
The posterior conditional distributions for the Bayesian backfitting algorithm are as follows. For simplicity we assume that target covariate values t are on a common discrete grid, though this is not a requirement.
For updating (σ 2 |. . .), the prior, likelihood, and full conditional distributions are
• Prior:
• Likelihood:
• Full conditional:
For updating γ 2 µ . . . , the prior, likelihood, and full conditional distributions are For updating (b 1 |. . .), the prior, likelihood, and full conditional distributions are
• Full conditional: , 1 , and the likelihood is computed using the control observations, as opposed to treatment. The full conditional is then similar to that of b 1 .
For updating (η µ |. . .), the prior, likelihood, and full conditional distributions are
• Likelihood: For updating µ (t i , x i ,π i ) and τ (t i , x i ), the priors are tsbcf; updates are performed via the Bayesian backfitting algorithm, using the partial residuals as described previously. For updating prognostic trees T µj , the marginal likelihood uses homogeneous variances, similar to the marginal likelihood in tsBART. For updating treatment trees T τ j , the marginal likelihood is similar, but for heterogeneous variances. See the following sections for further detail.
Marginal likelihood for prognostic tree updates
The marginal likelihood for updating the prognostic tree fits µ(t i , x i ,π i ) is the homogeneous version from BART with Targeted Smoothing. We derive the marginal loglikelihood here for a single leaf. In the Backfitting algorithm, this is calculated for multiple leaves depending on whether a birth move or death move is proposed for the tree. The likelihoods are then used in calculating the acceptance probability for the Metropolis step.
Let y l represent the length n l vector of residuals for a given leaf. Let T µj be the tree structure for the jth tree, and t len be the length of the grid of unique target values. We integrate out leaf means vector m l to obtain the marginal log-likelihood as follows.
p(y l |T j , σ 2 ) =
